Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.3.1.2 extracted from

  • West, T.P.
    Pyrimidine base catabolism in Pseudomonas putida biotype B (2001), Antonie van Leeuwenhoek, 80, 163-167.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
chloramphenicol 2.0fold reduced activity in chloramphenicol-treated cells Pseudomonas putida

Organism

Organism UniProt Comment Textmining
Pseudomonas putida
-
biotype B, strain ATCC 17536
-

Specific Activity [micromol/min/mg]

Specific Activity Minimum [µmol/min/mg] Specific Activity Maximum [µmol/min/mg] Comment Organism
0.00018
-
at 30°C Pseudomonas putida

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
thymine + NAD(P)H + H+
-
Pseudomonas putida 5,6-dihydrothymine + NAD(P)+
-
?
uracil + NAD(P)H + H+
-
Pseudomonas putida 5,6-dihydrouracil + NAD(P)+
-
?

Synonyms

Synonyms Comment Organism
dihydropyrimidine dehydrogenase
-
Pseudomonas putida

Cofactor

Cofactor Comment Organism Structure
NAD(P)H
-
Pseudomonas putida